SCHEMBL3324051

SCHEMBL3324051

FC(F)(F)c1ccc(Cl)cc1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ TMPRSS4 Q9NRS4 4/20 0.41
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ EPAS1 Q99814 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ NOS3 P29474 1/20 0.36
▸ NOS1 P29475 1/20 0.36
▸ NOS2 P35228 1/20 0.36
▸ PTP4A3 O75365 1/20 0.36
▸ PDK2 Q15119 1/20 0.35
▸ AR P10275 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29890650 1.00 NOTUM (0.44) NOTUML3MBTL1CYP3A4TSHRMAPK1
SCHEMBL1410268 0.82 TMPRSS4 (0.51) NOTUML3MBTL1CYP3A4TSHRMAPK1
SCHEMBL31193921 0.82 TMPRSS4 (0.51) NOTUML3MBTL1CYP3A4TSHRMAPK1
SCHEMBL11550638 0.79 TSHR (0.60) L3MBTL1CYP3A4TSHRMAPK1TDP1
SCHEMBL3789153 0.78 CYP3A4 (0.52) CYP3A4TSHRMAPK1TDP1TMPRSS4
SCHEMBL12251280 0.77 TSHR (0.41) CYP3A4TSHRMAPK1TDP1CYP1A2
SCHEMBL672252 0.76 NOTUM (0.47) NOTUML3MBTL1TSHRMAPK1TDP1
SCHEMBL29403188 0.76 TSHR (0.62) NOTUMCYP3A4TSHRMAPK1TDP1
SCHEMBL107751 0.76 TSHR (0.62) NOTUMCYP3A4TSHRMAPK1TDP1
SCHEMBL5865588 0.75 CYP3A4 (0.53) NOTUML3MBTL1CYP3A4TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3433239-B1 SMALL MOLECULE INHIBITORS OF THE NUCLEAR TRANSLOCATION OF ANDROGEN RECEPTOR FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION (US) 2026-05-27 — — EP disclosed
US-20260070932-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF ANNEXON INC (US) 2026-03-12 — — US disclosed
US-12509474-B2 Inhibitors of complement factors and uses thereof ANNEXON, INC. (US) 2025-12-30 — — US disclosed
WO-2025085554-A1 LYSINE ACETYLTRANSFERASE INHIBITORS Kronos Bio, Inc. (US) 2025-04-24 — — WO disclosed
US-20240109920-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF ANNEXON, INC. 2024-04-04 — — US disclosed
US-11814404-B2 Inhibitors of complement factors and uses thereof ANNEXON, INC. (US) 2023-11-14 — — US disclosed
CN-116947903-A Inhibitors of complement factors and uses thereof 安尼艾克松股份有限公司 2023-10-27 — — CN disclosed
US-11766433-B2 Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2023-09-26 — — US disclosed
CN-116261564-A Inhibitors of complement factors and uses thereof 安尼艾克松股份有限公司 2023-06-13 — — CN disclosed
EP-4185592-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF Annexon, Inc. (US) 2023-05-31 — — EP disclosed
US-20100179126-A1 THIOLACTAMS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-07-15 — — US disclosed
US-20100179126-A1 THIOLACTAMS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-07-15 — — US disclosed
WO-2010065134-A1 5, 7-DIHYDRO- 6H-PYRIMIDO [ 5, 4-D] [ 1 ] BENZAZEPIN-6-THIONES AS PLK INHIBITORS MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-06-10 — — WO disclosed
US-20100137608-A1 POLY-N-HETEROCYCLIC CARBENE TRANSITION METAL COMPLEXES AND N-HETEROCYCLIC CARBENE TRANSITION METAL COMPLEXES FOR CARBON-SULFUR AND CARBON-OXYGEN COUPLING REACTIONS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2010-06-03 — — US disclosed
US-4659370-A Substituted phenoxypropionates and herbicidal compositions containing same and their herbicidal use NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1987-04-21 — — US disclosed
US-4614536-A Certain pyridyloxy-phenoxy-propionate derivatives, herbicidal compositions containing same and their herbicidal method of use NIHON TOKUSHU NOYAKU SEIZO, K.K. (JP) 1986-09-30 — — US disclosed
CN-85108797-A A kind of preparation method of new benzoylphenylurea derivative and as the application of sterilant — 1986-09-24 — — CN disclosed
US-4536344-A USING A PHOSPINE OR PHOSPHITE BAYER AKTIENGESELLSCHAFT (DE) 1985-08-20 — — US disclosed
US-4500346-A Substituted phenoxypropionates and herbicidal compositions containing same and their herbicidal use NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1985-02-19 — — US disclosed
EP-0109606-A1 Process for the formylation of aryl halides BAYER AG (DE) 1984-05-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109920-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF CFB, CFH, C9 NOTUM 509/4885L3MBTL1 4785/4885CYP3A4 2694/4885
US-20100137608-A1 POLY-N-HETEROCYCLIC CARBENE TRANSITION METAL COMPLEXES AND N-HETEROCYCLIC CARBENE TRANSITION METAL COMPLEXES FOR CARBON-SULFUR AND CARBON-OXYGEN COUPLING REACTIONS SCO2, CYCS, NCLN NOTUM 2872/4885L3MBTL1 3498/4885CYP3A4 2018/4885
US-11814404-B2 Inhibitors of complement factors and uses thereof CFB, CFH, C9 NOTUM 509/4885L3MBTL1 4785/4885CYP3A4 2694/4885
US-20100179126-A1 THIOLACTAMS AND USES THEREOF PLK3, PLK4, PLK2 NOTUM 1618/4885L3MBTL1 135/4885CYP3A4 2521/4885
US-12509474-B2 Inhibitors of complement factors and uses thereof SSB, UACA, CFH NOTUM 3713/4885L3MBTL1 2967/4885CYP3A4 4043/4885
US-20260070932-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF CFH, CFB, C5 NOTUM 1663/4885L3MBTL1 3721/4885CYP3A4 3719/4885
US-11766433-B2 Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer AR, NR0B1, NCOA3 NOTUM 3083/4885L3MBTL1 3218/4885CYP3A4 1692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback